Since 2009, six prominent US sterile-injectable drug makers have received FDA warnings regarding manufacturing procedures. As a result, the manufacturing capacity for injectables has been reduced by almost one-third, according to a congressional report. Four of the firms shut down or decreased production to address the issues. Compounding pharmacies have attempted to provide the products, […]
Development of a new type of preventive cancer vaccine is generating funding for biotechnology firms and hope for new therapies. The first such vaccine to come to market was Dendreon’s Provenge, which won FDA approval in 2010 for the treatment of metastatic prostate cancer and is customized for each patient. The new approach seeks to […]
A report released this month by the Department of Health and Human Services’ (DHHS) Office of Inspector General indicates that many of the 127 immune support and weight loss supplements it analyzed did not adhere to FDA guidance. The Inspector General found that 20% of the supplements’ labels included illegal claims to prevent, diagnose or […]
A July survey of 156 chemical industry senior executives found that 63% plan to increase capital spending next year, with 81% of Asian executives expecting to do so. In 2012, 38% of executives expect to invest between 3% to 5% of revenues in R&D, while 31% expect to invest between 2% and 3%. Eighty percent […]
R&D investment by the one thousand public companies that spend the most on R&D increased 9.6% in 2011 to $603 billion after a 9.3% increase the previous year, according to Booz & Company’s eighth annual “Global Innovation 1000” report. R&D spending by the computing and electronics, health care and automobile industries accounted for 28%, 21% […]
This month, 10 major drug firms announced their participation in TransCelerate BioPharma, the largest-ever collaboration to speed up drug development. Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Roche’s Genentech and Sanofi will pool funds and personnel for TransCelerate projects, which will initially focus on five projects for streamlining clinical […]
In February 2013, the University of Texas MD Anderson Cancer Center will begin a research program that will initially focus on eight types of cancer. The Moon Shots Program will create six teams of scientists and clinicians to work on projects to develop tests, drugs and policies. Unlike the past, the teams will share infrastructure […]
Despite Congress having passed a continuing resolution to maintain federal agencies’ budgets through the first half of fiscal 2013 (see IBO 8/15/12), the American Association for the Advancement of Science (AAAS) estimates that sequestration could result in a federal R&D budget cut of $57.5 billion, or 8.4%, through 2017. Budgets for nondefense R&D at science […]
Semiconductor firms’ R&D spending is forecast to grow 10% this year to $53.4 billion. In 2011, 12 companies spent more than $1 billion on R&D, with Intel accounting for 17% of the semiconductor industry’s total R&D spending. US, Japanese and European companies accounted for 57%, 17% and 10% of worldwide semiconductor R&D spending last year. […]
According to the Organization for Economic Co-operation and Developments’ (OECD) “OECD Science, Technology and Industry Outlook 2012,” countries face new challenges to spur innovation in the face of economic constraints. Following the economic crisis, total R&D investments by businesses in OECD member countries declined 4.5% in 2009. Future growth for such expenditures is expected to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
